June 19, 2006 NASD OTC-BB: MRDAF

Meridian will be Attending In3 Medical Device Summit: June 21st-June 23rd in San Francisco

Representatives of Meridian Co., Ltd. (OTC BB:MRDAF.OB - News) will be attending the In3 Medical Device Summit in San Francisco, CA from June 21-23 to promote their medical devices: The Digital Pulse Analyzer and The Lipo-Laser.

The In3 Medical Device Summit is the most important venue of its kind for previewing cutting-edge emerging medical technology companies and for engaging with the biggest dealmakers in the industry, including senior executives from the device industry and healthcare investment community, all in a short period of time. All attendees will benefit from the mix of quality presentations, speakers, roundtables, workshops and panels addressing the hottest topics in the ever-more competitive and lucrative medical technology marketplace, along with the unmatched networking and partnering opportunities that attendees have come to expect from Investment In Innovation (In3) events over the past 5 years.

Meridian is looking forward to meeting with the Investment and Medical communities as they showcase their Digital Pulse Analyzer (DPA) and their newest medical device The Lipo-Laser.

Meridian Co., Ltd. will have a presentation booth where all attendees are encouraged to visit. The booth will be available to Meridian guests all day Thursday June 21st along with a 10:40 a.m. Power Point presentation on Friday June 23rd. The Power Point presentation will focus mainly on the Digital Pulse Analyzer; information on the Lipo-Laser will also be available.

About Digital Pulse Analyzer (DPA)

The DPA accurately measures the elasticity of small and large arteries and provides health care practitioners with critical information regarding arterial aging. This FDA-approved device is inexpensive, non-invasive and can provide results in minutes. Accumulating evidence suggests that abnormalities in the pulsatile characteristics of arteries occur early in the disease process associated with increased cardiovascular risk, and can be favorably modified by therapeutic interventions.

Meridian feels that use of the DPA can help caregivers reduce cardiovascular disease in their patient populations through early detection and prevention and ultimately assist to decrease the associated financial costs placed on the healthcare industry. Cardiovascular disease is the number one killer in the United States with an estimated economic cost of approximately $298 billion.

About: Lipo-Laser

The Lipo-Laser's non-invasive treatment is considered one of the most innovative methods to reduce the appearance of cellulite and improve body contour. The demand for this type of treatment is expected to grow rapidly, in any clinical setting, spa or wellness centers that treat stubborn areas of the body which may not have responded to diet and exercise.

More About: Meridian

Meridian is an established leader in the research/development, manufacturing, and sales of integrative medical diagnostic equipment. The company sells its products and equipment to a wide array of customers in the global health care industry. The company presently holds a total of 18 worldwide patents on its technology, and has received FDA approval, as well as other international regulatory approvals for many of its products.

Meridian is committed to the ongoing global research and advancement of integrative medical products that contribute to the better health of humanity.

On Behalf of the Board of Directors,

Hyeon Seong Myeong, President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the company.

Contact:

Meridian Co., Ltd.
Tariq Tyab
Corporate Communications
1-877-738-8119
[email protected]
https://MeridianMedical.ca